| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2021: ¥260,000 (Direct Cost: ¥200,000、Indirect Cost: ¥60,000)
Fiscal Year 2020: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2019: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
|---|
| Outline of Final Research Achievements |
The aims of this study were to clarify the prevalence of asymptomatic cortical microhemorrhage, related local brain atrophy, and blood biomarkers in community-dwelling older people. We showed that the prevalence of asymptomatic cortical microhemorrhage was 2.5% of the older adults with normal cognitive function. The right parahippocampal volume of the people with asymptomatic cortical microhemorrhage showed significantly lower than that of the people without microhemorrhage. Furthermore, the people with asymptomatic cortical microhemorrhage showed significantly higher fasting blood sugar levels, which suggests a relationship between glucose dysmetabolism and asymptomatic cortical microhemorrhage.
|
